Tamoxifen treatment and pulmunary embolism: a case report and literature review

  • Gregoriana Zanini | gregoriana.zanini@aod.it U.O. C. Cardiologia/UTIC, Ospedale La Memoria di Gavardo (Brescia), Italy.
  • Benedetta Fontanella U.O. C. Cardiologia/UTIC, Ospedale La Memoria di Gavardo (Brescia), Italy.
  • Marco Racheli U.O. C. Cardiologia/UTIC, Ospedale La Memoria di Gavardo (Brescia), Italy.
  • Monica Bortolotti U.O. C. Cardiologia/UTIC, Ospedale La Memoria di Gavardo (Brescia), Italy.
  • Gianfranco Pasini U.O. C. Cardiologia/UTIC, Ospedale La Memoria di Gavardo (Brescia), Italy.

Abstract

Breast carcinoma is becoming a spread disease that needs a specif teraphy. Tamoxifen is the first line treatment in patients with positivity of expression of estrogen receptors. The risk of thromboembolism is high in patients treated with tamoxifene indipendent from the neoplastic disease. This work focuses the attention on tamoxifen mechanism of thrombosis.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.
Published
2015-11-25
Info
Issue
Section
Case Reports
Keywords:
thrombosis, tamoxifen, pulmunary embolism
Statistics
  • Abstract views: 786

  • PDF: 776
How to Cite
Zanini, G., Fontanella, B., Racheli, M., Bortolotti, M., & Pasini, G. (2015). Tamoxifen treatment and pulmunary embolism: a case report and literature review. Monaldi Archives for Chest Disease, 80(1). https://doi.org/10.4081/monaldi.2013.91